10402-56-9 Usage
Uses
Used in Medicinal Chemistry Research:
3-(3,5-DIIODO-4-HYDROXYBENZOYL)-2-METHYL-BENZOFURAN is used as a research compound for exploring its potential biological activities and interactions with various molecular targets. Its unique structure allows for the investigation of its effects on different biological pathways and mechanisms, contributing to the advancement of medicinal chemistry.
Used in Drug Development:
In the pharmaceutical industry, 3-(3,5-DIIODO-4-HYDROXYBENZOYL)-2-METHYL-BENZOFURAN is used as a building block for the synthesis of other compounds with therapeutic potential. Its molecular structure can be modified or combined with other chemical entities to create new drug candidates with improved pharmacological properties, such as enhanced efficacy, selectivity, and reduced side effects.
Used in Chemical Synthesis:
3-(3,5-DIIODO-4-HYDROXYBENZOYL)-2-METHYL-BENZOFURAN is utilized as a key intermediate in the synthesis of various organic compounds for different purposes. Its versatile structure allows for further functionalization and modification, enabling the development of new molecules with specific properties and applications in various fields, such as materials science, agrochemistry, and environmental chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 10402-56-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,0 and 2 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 10402-56:
(7*1)+(6*0)+(5*4)+(4*0)+(3*2)+(2*5)+(1*6)=49
49 % 10 = 9
So 10402-56-9 is a valid CAS Registry Number.
10402-56-9Relevant academic research and scientific papers
Synthesis and preliminary characterization of a novel antiarrhythmic compound (KB130015) with an improved toxicity profile compared with amiodarone
Carlsson, Bo,Singh,Temciuc, Marcel,Nilsson, Stefan,Li, Yi-Lin,Mellin, Charlotta,Malm, Johan
, p. 623 - 630 (2007/10/03)
Recent developments in antiarrhythmic therapy have indicated that the best approach to pharmacologically controlling supraventricular arrhythmias and life-threatening ventricular tachyarrhythmias is by prolonging cardiac repolarization rather than by bloc
